157 related articles for article (PubMed ID: 17665945)
1. Nanoparticles incorporated in bilaminated films: a smart drug delivery system for oral formulations.
Cui F; He C; Yin L; Qian F; He M; Tang C; Yin C
Biomacromolecules; 2007 Sep; 8(9):2845-50. PubMed ID: 17665945
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin.
Cui F; He C; He M; Tang C; Yin L; Qian F; Yin C
J Biomed Mater Res A; 2009 Jun; 89(4):1063-71. PubMed ID: 18478558
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
5. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
8. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
10. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
13. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
Wang Tw; Xu Q; Wu Y; Zeng Aj; Li M; Gao H
Carbohydr Res; 2009 May; 344(7):908-14. PubMed ID: 19303066
[TBL] [Abstract][Full Text] [Related]
14. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
Qian F; Cui F; Ding J; Tang C; Yin C
Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
[TBL] [Abstract][Full Text] [Related]
15. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
[TBL] [Abstract][Full Text] [Related]
16. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
17. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
Grenha A; Remuñán-López C; Carvalho EL; Seijo B
Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
[TBL] [Abstract][Full Text] [Related]
18. Thiomer nanoparticles: stabilization via covalent cross-linking.
Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
[TBL] [Abstract][Full Text] [Related]
19. Design and development of a mucoadhesive buccal film bearing progesterone.
Jain SK; Jain A; Gupta Y; Kharya A
Pharmazie; 2008 Feb; 63(2):129-35. PubMed ID: 18380399
[TBL] [Abstract][Full Text] [Related]
20. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
